Other Challenges With Bronchiectasis and Key Takeaways

An exploration of idiopathic bronchiectasis, emphasizing the importance of patient participation in clinical trials to advance knowledge and treatment options for this condition, along with concluding thoughts and key takeaways on the management and understanding of bronchiectasis.

EP: 1.Overview of Bronchiectasis

EP: 2.Prognosis For Patients Diagnosed With Bronchiectasis

EP: 3.Indicators Leading to Bronchiectasis Testing and Diagnosis

EP: 4.Complications Associated With Bronchiectasis

EP: 5.Current Treatment Options For Bronchiectasis

EP: 6.Respiratory and Physical Therapists Contributing to Comprehensive Bronchiectasis Care

EP: 7.Key Areas of Research and Emerging Therapies In Bronchiectasis Treatment

EP: 8.Diagnosing and Understanding the Pathogenesis of Bronchiectasis

EP: 9.Improving Long-Term Outlook: CT Scans and Underdiagnosis of Bronchiectasis

EP: 10.Bronchiectasis Exacerbation Management

EP: 11.Social Burden and Goals of Therapy for Patients with Bronchiectasis

EP: 12.Patient Specific Factors: Guiding Treatment in Bronchiectasis

EP: 13.Individualized Therapy for Specific Infections Associated with Bronchiectasis

Now Viewing

EP: 14.Other Challenges With Bronchiectasis and Key Takeaways

EP: 15.Identifying Bronchiectasis: Key Clinical Presentations to Consider

EP: 16.Differentiating Bronchiectasis from COPD and Understanding Exacerbations

EP: 17.Long-Term Impact of Bronchiectasis Exacerbations: Disease Progression, Patient Outcomes, and Economic Burden

EP: 18.Managing Bronchiectasis: Treatment Goals, Outcome Measures, and Clinical Decision Resources

EP: 19.Addressing Knowledge Gaps and Treatment Strategies in Bronchiectasis

EP: 20.Challenges and Future Directions in Bronchiectasis Management

Related Videos

Related Content

Advertisement

December 16th 2024

Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

Pearl Steinzor

Both candidates combine 2 already licensed vaccines to prevent influenza and COVID-19.

June 1st 2021

Preventing Respiratory Illness and Death Through Tighter Air Quality Standards

On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.

December 6th 2024

Nirsevimab Protected Infants, Children From Severe RSV in 2023–2024 Season

Pearl Steinzor

New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory syncytial virus (RSV).

May 4th 2021

How Has COVID-19 Impacted the Allergy and Immunology Field?

Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.

November 20th 2024

Study Highlights Key RA-ILD Risk Factors, Urges Early Screening

Brooke McCormick

This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.

November 12th 2024

Novel, AI-Procured ISM001-055 Demonstrates Great Promise for Treatment of IPF

Kyle Munz

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options for patients with idiopathic pulmonary fibrosis (IPF).

Related Content

Advertisement

December 16th 2024

Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

Pearl Steinzor

Both candidates combine 2 already licensed vaccines to prevent influenza and COVID-19.

June 1st 2021

Preventing Respiratory Illness and Death Through Tighter Air Quality Standards

On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.

December 6th 2024

Nirsevimab Protected Infants, Children From Severe RSV in 2023–2024 Season

Pearl Steinzor

New York City data highlight the benefits of early administration of nirsevimab to safeguard infants from respiratory syncytial virus (RSV).

May 4th 2021

How Has COVID-19 Impacted the Allergy and Immunology Field?

Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.

November 20th 2024

Study Highlights Key RA-ILD Risk Factors, Urges Early Screening

Brooke McCormick

This recent study highlights key risk factors for rheumatoid arthritis–associated interstitial lung disease (RA-ILD), emphasizing the importance of early screening to improve diagnosis and patient outcomes.

November 12th 2024

Novel, AI-Procured ISM001-055 Demonstrates Great Promise for Treatment of IPF

Kyle Munz

The development of a novel, artificial intelligence (AI)-generated biotechnology has the potential to transform care options for patients with idiopathic pulmonary fibrosis (IPF).